Efficacy, cardiotoxicity and factors affecting pathologic complete response of neoadjuvant chemotherapy with anthracycline-containing verses anthracycline-free regimens plus dual HER2 blockade for HER2-positive early-stage breast cancer: a retrospective study

BACKGROUND: The aim of this study was to compare the efficacy, cardiotoxicity and factors affecting pathologic complete response (pCR) of neoadjuvant chemotherapy (NACT) regimen TCbHP (docetaxel/nab-paclitaxel, carboplatin, trastuzumab and pertuzumab) and AC-THP (doxorubicin, cyclophosphamide follow...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Hang, Yan, Han, Liao, Shichong, Deng, Jingwen, Zhang, Jiucheng, Yao, Feng, Zheng, Hongmei, Sun, Shengrong, Zhang, Yimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331454/
https://www.ncbi.nlm.nih.gov/pubmed/37434677
http://dx.doi.org/10.21037/tcr-22-2547

Ejemplares similares

Ejemplares similares